| Print
XOMA Royalty Corporation (XOMA)
Common SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
Address
1209 Orange Street
Corporation Trust Center
Wilmington
DE
USA
19801
Telephone
+1 510 204-7200
Forecast key dates
| Name | Key Date |
|---|---|
| XOMA Royalty Corp Second Quarter Earnings Results for 2026 | 2026-08-13T00:00:00 |
| XOMA Royalty Corp Annual General Meeting for 2026 | 2026-05-21T09:00:00 |
| XOMA Royalty Corp First Quarter Earnings Results for 2026 | 2026-05-13T00:00:00 |
| XOMA Royalty Corp Fourth Quarter Earnings Results for 2025 | 2026-03-17T04:30:00 |
| XOMA Royalty Corp Annual Report for 2025 | 2026-03-17T00:00:00 |
| XOMA Royalty Corp Third Quarter Earnings Results for 2025 | 2025-11-07T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference | 2025-09-08T09:00:00 |
| XOMA Royalty Corp Second Quarter Earnings Results for 2025 | 2025-08-13T00:00:00 |
| XOMA Royalty Corp Annual General Meeting for 2025 | 2025-05-21T09:00:00 |
| XOMA Royalty Corp First Quarter Earnings Results for 2025 | 2025-05-13T00:00:00 |
| Jones Healthcare and Technology Innovation Conference | 2025-04-09T10:30:00 |
| XOMA Royalty Corp Fourth Quarter Earnings Results for 2024 | 2025-03-17T04:30:00 |
| XOMA Royalty Corp Annual Report for 2024 | 2025-03-17T00:00:00 |
| Leerink's Global Healthcare Conference 2025 | 2025-03-10T14:20:00 |
| TD Cowen 45th Annual Health Care Conference | 2025-03-03T11:10:00 |
| Oppenheimer 35th Annual Healthcare Life Sciences Conference | 2025-02-11T15:20:00 |
| XOMA Royalty Corp Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.